Retina Consultants of America

Retina Consultants of America (RCA) is the largest management services organization (MSO) and clinical research network dedicated to retinal healthcare in the United States. Headquartered in Southlake, Texas, the company manages a vast network of premier retina specialist practices and operates over 40 dedicated clinical trial sites across 23 states. RCA is a global leader in ophthalmic research, conducting high-volume Phase 1-4 clinical trials for major pharmaceutical and biotechnology sponsors focused on innovative treatments for blinding diseases. The organization leverages an extensive real-world evidence (RWE) database and AI-driven analytics to improve clinical outcomes and accelerate drug development in ophthalmology. In early 2025, Cencora (formerly AmerisourceBergen) completed its acquisition of RCA for approximately $4.6 billion, integrating the network into its global specialty healthcare and clinical research infrastructure.